Is It Working: AutoImmune 

Monitoring Clinical Markers

1. Immune Activity & Inflammation

  • Flare frequency: Are autoimmune flare-ups (e.g. joint pain, rashes, digestive flares) happening less often?

  • Flare intensity: Do flares resolve faster, or feel less severe?

  • CRP or ESR (if monitored): Stabilization or reduction over months.

  • Pain and swelling: More “calm days” with less joint/tissue swelling.

 A drop in flare frequency or severity over 2–6 months is one of the clearest markers.

2. Gut & Digestive Function

  • Bloating / discomfort: Reduction in daily digestive irritation.

  • Bowel regularity: More stable rhythm (marshmallow root mucilage + burdock support barrier healing).

  • Food tolerance: Fewer foods triggering symptoms.

  • Nutrient absorption: Gradual improvement in energy (iron, B12, minerals stabilize).

 Early gut shifts can appear in weeks, while deeper tolerance takes 3–6 months.

3. Energy & Fatigue

  • Morning energy: Less post-sleep heaviness, more ability to start the day.

  • Crash cycles: Fewer severe mid-day or post-activity energy crashes.

  • Stamina: Can do a bit more physical or cognitive work without a flare.

 Valerian + lotus help sleep restoration; schisandra and burdock support steady metabolic energy.

4. Mood & Sleep

  • Sleep continuity: Longer sleep stretches without waking from pain or anxiety.

  • Anxiety: Less preoccupation with symptoms; calmer nervous system baseline.

  • Mood swings: More emotional stability.

 These tend to shift within the first 1–2 months if tincture is tolerated and consistent.

5. Immune Lab Markers (optional if patient is monitored)

  • Autoantibodies: In some cases (thyroid, ANA, RF, etc.), stabilization rather than steady rise.

  • White blood cell count: Less fluctuation, no chronic leukocytosis.

  • Liver/kidney labs: Indicating less systemic inflammation burden.

6. Quality of Life Indicators

  • Daily function: More days in a row where normal activities are possible without extra rest.

  • Fewer “sick days”: Longer stretches of symptom-free days.

  • Medication reliance: Over many months, possible reduction in need for rescue meds (if supervised).

7. Trajectory Markers (long view)

  • Plateau in disease activity: After 6–12 months, the illness hasn’t advanced (e.g., no new organs/tissues involved, no escalation in baseline symptoms).

  • Less new damage: Stabilized or slowed lab/imaging findings if tracked medically.

  • Hospital visits avoided: No ER trips or urgent care for flares.

 Timeline expectations:

  • Weeks (2–6): early digestion/sleep/mood shifts.

  • Months (3–6): fewer or milder autoimmune flares.

  • Year (6–12 months): plateau in disease progression; slower rise (or stabilization) of antibodies and inflammatory markers.